Q2 FY2026 · ended Jun 30, 2026 · Revenue $848.90M, +2.7% YoY · Filed Aug 10, 2026
Surgery Partners, Inc. (SGRY) files with the SEC under industry code 8062, Services-General Medical & Surgical Hospitals, NEC. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $848.9 million and a net loss of $15.0 million. Free cash flow was $37.5 million. As of Jun 30, 2026 it held $216.7 million in cash and investments and $4.0 billion in total debt.
Company profile
- Industry
- Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
- Listed as
- SGRY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brentwood, TN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1638833
Other Services-General Medical & Surgical Hospitals, NEC companies
- HCA Healthcare, Inc. HCA
- Tenet Healthcare Corp THC
- Universal Health Services Inc UHS
- Ardent Health, Inc. ARDT
- Community Health Systems Inc CYH
All 6 Services-General Medical & Surgical Hospitals, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $848.9M | $810.9M | $885.0M | $821.5M | $826.2M |
| Operating income | $102.1M | $65.8M | $110.2M | $105.7M | $111.7M |
| Net income | -$15.0M | -$35.9M | -$15.0M | -$22.7M | -$2.5M |
| Diluted EPS | -$0.12 | -$0.28 | -$0.12 | -$0.18 | -$0.02 |
| Operating cash flow | $59.3M | $11.7M | $103.4M | $83.6M | $81.3M |
| Free cash flow | $37.5M | -$4.3M | $90.6M | $63.8M | $57.9M |
| Total assets | $8.0B | $8.0B | $8.1B | $7.9B | $8.0B |
| Stockholders' equity | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B |
| Cash and investments | $216.7M | $182.3M | $239.9M | $203.4M | $250.1M |
| Total debt | $4.0B | $3.9B | $5.0B | $3.8B | $3.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 26, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Sep 17, 2026 | Sep 14, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 24, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 5, 2026 |
All 847 Surgery Partners, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.